Saturday , July 4 2020
Home / Audit and Guideline (page 4)

Audit and Guideline

USFDA Warning Letter for JHS Svendgaard Hygiene Products Ltd

JHS Svendgaard Hygiene Products Ltd MARCS-CMS 593473 — February 13, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …

Read More »

USFDA Warning Letter for KVK-Tech, Inc

KVK-Tech, Inc MARCS-CMS 592387 — February 11, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …

Read More »

USFDA Warning Letter for Chemland Co., Ltd.

Chemland Co., Ltd. MARCS-CMS 593158 — February 11, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …

Read More »

USFDA Warning Letter for Acino Products, LLC

Acino Products, LLC MARCS-CMS 589471 — February 10, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …

Read More »

USFDA Warning Letter for Guangzhou Tinci Materials Technology

Guangzhou Tinci Materials Technology Co., Ltd. MARCS-CMS 592199 — January 23, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For …

Read More »

USFDA Warning Letter for Windlas Healthcare Private Limited

Windlas Healthcare Private Limited MARCS-CMS 595494 — March 10, 2020   For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …

Read More »

USFDA Warning Letter for Cipla Limited

Cipla Limited MARCS-CMS 597511 — February 25, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …

Read More »

USFDA Warning Letter for Hangzhou Linkeweier

Hangzhou Linkeweier Daily Chemicals Co., Ltd. MARCS-CMS 595492 — March 13, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For …

Read More »

USFDA Warning Letter for Derma Pharm

Derma Pharm A/S MARCS-CMS 596662  March 10, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …

Read More »

USFDA Warning Letter for Pfizer Healthcare India Private Limited

Pfizer Healthcare India Private Limited MARCS-CMS 594972 — March 25, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …

Read More »